Authors
Latest:
Cost Utility of Hub-and-Spoke Telestroke Networks From Societal PerspectiveA cost-utility analysis of a hub-and-spoke telestroke network showed that it was economically dominant over routine care.
Latest:
An Expanded Portfolio of Survival Metrics for Assessing Anticancer AgentsA novel, simplified cost-value analysis tool was created to better differentiate the value of anticancer agents and further characterize the expected survival benefit of all patients.
Latest:
Projected US Savings From Biosimilars, 2021-2025Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound scenario.
Latest:
Implications of DRG Classification in a Bundled Payment Initiative for COPDDiagnosis-related group coding determines eligibility for many Medicare bundled payment initiatives. This approach excluded many patients with chronic obstructive pulmonary disease likely to benefit while including others without the disease.
Latest:
False-Positive Mammography and Its Association With Health Service UseThis study demonstrated that a false-positive mammogram was associated with increases in outpatient visits, but not provider referrals, for 1 year post mammogram.
Latest:
Effects of Nonadherence With Prescription Drugs Among Older AdultsPrescription nonadherence in older patients with chronic health conditions resulted in more emergency department use.
Latest:
Change to FIT Increased CRC Screening Rates: Evaluation of a US Screening Outreach ProgramFecal immunochemical testing resulted in higher colorectal cancer screening rates than did guaiac fecal occult blood tests, with less dependence on office visits.
Latest:
Relationship of Diabetes Complications Severity to Healthcare Utilization and Costs Among Medicare Advantage BeneficiariesThis retrospective cohort study in a Medicare Advantage population posits that type 2 diabetes mellitus complications pose an excess burden on healthcare resource use and related costs.
Latest:
Predictive Factors of Discharge Navigation Lag TimeExamination of factors associated with discharge lag time and how this metric plays an important role in managing hospital throughput.
Latest:
Health Care Resource Utilization Among Patients With T2D and Cardiovascular-, Heart Failure–, or Renal-Related HospitalizationsAmong patients with type 2 diabetes (T2D), concurrent cardiovascular-, heart failure–, or renal-related hospitalization presents significant disease burden leading to poor quality of life.
Latest:
To Report or Not Report Health Care Data BreachesThis study presents information regarding the decisions that health care privacy officers make about reporting a data breach, including factors that can affect the decision process, such as personal/organizational knowledge, prior breach status, and framed scenarios.
Latest:
Prescription Opioid Abuse: Challenges and Opportunities for PayersThis article outlines strategies insurers can use to mitigate their risks related to prescription opioid abuse by members, while addressing this serious public health problem.
Latest:
Adding Glucose-Lowering Agents Delays Insulin Initiation and Prolongs HyperglycemiaA review of national Veterans Health Administration data has identified how the number of glucose-lowering agents used prior to insulin initiation impacts glycemic control.
Latest:
Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMITThis cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.
Latest:
Examining Differential Performance of 3 Medical Home Recognition ProgramsWe examine utilization, quality, and expenditures among Medicare beneficiaries receiving care at federally qualified health centers and compare outcomes among those attributed to 1 of 3 recognition programs versus none.
Latest:
A Managed Care Organization's Call Center–Based Social Support RoleThis study describes an alternative approach to linking patients to community resources, such as food banks, housing, and medical transport, using a call center–based layperson role.
Latest:
Effect of Inadequate Response to Treatment in Patients With DepressionPatients with inadequate response to depression treatment used increased resources, were less likely to be employed, and had more presenteeism than those with treatment response.
Latest:
Payer Effects of Personalized Preventive Care for Patients With DiabetesWe examine the effects of MD–Value in Prevention (MDVIP) enrollment on Medicare expenditures and utilization among fee-for-service beneficiaries with diabetes over a 5-year period.
Latest:
A Retrospective on the Oncology Care ModelFlatiron Health recently conducted a retrospective review of the Oncology Care Model, discovering what's working, what isn't, and what this could mean for the future.
Latest:
Two-Sided Risk in the Oncology Care ModelThe US healthcare system remains one of the most inefficient healthcare systems in the world. The Bloomberg Health-Care Efficiency Index ranked the United States 54th among 56 countries in 2018, tied with Azerbaijan and only ahead of Bulgaria. This occurs even though the United States spends $10,244 per capita annually on healthcare, a figure representing 17% of the gross domestic product.
Latest:
The Duration of Office Visits in the United States, 1993 to 2010Nationally representative data show that outpatient office visits to both primary care physicians and specialists grew longer over the period from 1993 to 2010.
Latest:
Cost Differential by Site of Service for Cancer Patients Receiving ChemotherapyThe cost of care for patients receiving chemotherapy in community oncology clinics is lower than for comparable patients receiving chemotherapy in the hospital outpatient setting.
